Straumann Holding AG (SAUHY) Income Statement Analysis

See more : Manati Industries, Inc. (MNII) Income Statement Analysis – Financial Results

Complete financial analysis of Straumann Holding AG (SAUHY) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Straumann Holding AG, a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.

You may be interested

ImAlliance SA (MLIML.PA) Income Statement Analysis – Financial Results
Foshan Golden Milky Way Intelligent Equipment Co., Ltd. (300619.SZ) Income Statement Analysis – Financial Results
Cosco (India) Limited (COSCO.BO) Income Statement Analysis – Financial Results
AP Biosciences Inc (6945.TWO) Income Statement Analysis – Financial Results
Phatra Leasing Public Company Limited (PL.BK) Income Statement Analysis – Financial Results

Straumann Holding AG (SAUHY)

Industry: Medical - Instruments & Supplies

Sector: Healthcare

Website: https://www.straumann.com

About Straumann Holding AG

Straumann Holding AG provides tooth replacement and orthodontic solutions worldwide. It researches, develops, manufactures, and supplies dental implants, instruments, CADCAM prosthetics, orthodontic aligners, biomaterials, and digital solutions for use in tooth correction, replacement, and restoration, as well as to prevent tooth loss. The company offers dental implant systems for tissue and bone level; titanium, titanium alloy, ceramic, and mini dental implant systems; and guided and non-guided surgical instruments, as well as implant-borne prosthetics. It provides ceramic healing and screw retained abutments; intraoral scanning solutions; 3D printers; milling machines; and prevention products. In addition, it offers biomaterials, bone substitutes, membranes, biologics, and soft tissue management and oral healing products; digital solutions for dental labs, dentists, and centralized milling centers, as well as materials, third party systems, and guided surgery; surgical instruments comprising surgical and modular cassettes, guided instruments, implant maintenance products, bone block fixation sets, bonerings, titanium pin sets, and other cassettes; and edentulous, pro arch fixed, prosthetic, and mini implant solutions for edentulous patients. Further, it provides esthetic restorations that include ceramic implant monotypes, ceramic implants, abutments, biologics, and other solutions; and Emdogain for wound healing. Further, it offers systems Clear Correct aligners; and training and education services to its customers. The company provides its products to general dentists, specialists, and dental technicians and laboratories, as well as corporate customers, such as distributors, hospitals, universities, and dental service organizations in approximately 100 countries through a network of distribution subsidiaries and partners. Straumann Holding AG was founded in 1954 and is headquartered in Basel, Switzerland.

Metric	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2002
Revenue	2.41B	2.32B	2.02B	1.43B	1.60B	1.36B	1.11B	917.52M	798.60M	710.27M	679.92M	686.25M	693.58M	737.65M	736.36M	778.71M	713.65M	599.20M	509.55M	420.30M	343.87M	274.90M
Cost of Revenue	624.55M	566.05M	481.88M	396.07M	395.75M	344.32M	271.64M	198.99M	183.66M	151.62M	144.01M	154.73M	165.04M	150.63M	149.53M	147.21M	131.38M	58.26M	52.11M	45.42M	69.08M	54.36M
Gross Profit	1.79B	1.75B	1.54B	1.03B	1.20B	1.02B	840.46M	718.53M	614.94M	558.65M	535.92M	531.52M	528.54M	587.02M	586.83M	631.50M	582.27M	540.94M	457.44M	374.87M	274.79M	220.53M
Gross Profit Ratio	74.10%	75.61%	76.17%	72.22%	75.21%	74.75%	75.57%	78.31%	77.00%	78.65%	78.82%	77.45%	76.20%	79.58%	79.69%	81.10%	81.59%	90.28%	89.77%	89.19%	79.91%	80.22%
Research & Development	111.10M	104.60M	96.00M	128.56M	6.20M	6.15M	2.03M	0.00	0.00	0.00	1.13M	48.67M	39.02M	40.47M	39.11M	37.11M	31.23M	4.98M	4.87M	3.81M	34.75M	31.35M
General & Administrative	931.33M	781.27M	618.62M	580.23M	495.17M	389.02M	310.58M	282.73M	271.09M	244.11M	254.37M	0.00	0.00	0.00	0.00	0.00	-348.90M	-51.83M	-47.05M	-16.79M	19.68M	17.12M
Selling & Marketing	452.04M	442.98M	384.90M	311.77M	330.97M	291.02M	249.61M	211.00M	173.44M	168.46M	168.51M	423.61M	412.27M	385.07M	384.75M	556.65M	352.48M	81.14M	71.88M	48.65M	124.26M	97.29M
SG&A	1.20B	1.22B	1.00B	892.00M	826.14M	680.03M	560.19M	493.73M	444.53M	412.57M	422.88M	423.61M	412.27M	385.07M	384.75M	556.65M	3.58M	29.32M	24.83M	31.86M	143.94M	114.41M
Other Expenses	61.56M	4.86M	-493.00K	-13.90M	5.06M	3.42M	3.35M	2.12M	2.16M	2.15M	2.58M	1.73M	-2.67M	-2.83M	-2.37M	-2.67M	1.84M	1.35M	270.00K	212.23M	-3.14M	8.00K
Operating Expenses	1.38B	1.22B	1.00B	878.10M	826.14M	680.03M	560.19M	493.73M	444.53M	412.57M	422.88M	472.27M	448.62M	422.71M	421.50M	591.10M	382.65M	363.20M	301.82M	247.91M	175.56M	145.77M
Cost & Expenses	2.00B	1.79B	1.48B	1.27B	1.22B	1.02B	831.82M	692.72M	628.19M	564.19M	566.89M	627.01M	613.66M	573.34M	571.03M	738.30M	514.03M	421.46M	353.93M	293.33M	244.64M	200.13M
Interest Income	6.41M	2.58M	2.26M	1.46M	2.57M	1.29M	2.50M	2.31M	3.33M	1.06M	325.00K	611.00K	29.26M	28.05M	33.21M	33.96M	4.08M	1.65M	918.00K	1.27M	0.00	0.00
Interest Expense	17.95M	17.19M	17.04M	15.63M	17.62M	8.73M	6.02M	4.63M	4.46M	4.34M	3.70M	728.00K	31.57M	32.67M	25.38M	48.01M	6.57M	716.00K	543.00K	2.06M	0.00	0.00
Depreciation & Amortization	130.23M	162.71M	103.21M	99.47M	93.50M	52.37M	40.26M	32.02M	32.96M	27.89M	31.76M	34.89M	36.92M	47.62M	53.03M	61.02M	42.57M	42.52M	25.12M	29.02M	22.53M	18.60M
EBITDA	494.17M	678.33M	646.96M	229.00M	476.59M	403.73M	323.18M	258.86M	218.05M	175.69M	155.35M	93.57M	115.42M	239.68M	251.57M	135.38M	242.66M	217.20M	184.15M	155.20M	121.76M	93.37M
EBITDA Ratio	20.49%	29.28%	32.00%	17.86%	28.93%	28.74%	34.08%	28.06%	15.55%	29.47%	23.16%	12.80%	21.06%	32.53%	34.16%	17.39%	34.00%	36.76%	36.10%	36.93%	35.41%	33.96%
Operating Income	410.97M	535.35M	542.58M	156.54M	387.14M	342.64M	283.63M	227.18M	172.57M	148.32M	115.78M	61.01M	79.92M	164.31M	165.34M	40.41M	201.51M	175.32M	155.94M	126.97M	99.23M	74.76M
Operating Income Ratio	17.04%	23.07%	26.84%	10.98%	24.25%	25.13%	25.50%	24.76%	21.61%	20.88%	17.03%	8.89%	11.52%	22.27%	22.45%	5.19%	28.24%	29.26%	30.60%	30.21%	28.86%	27.20%
Total Other Income/Expenses	-65.35M	-36.92M	-65.19M	-42.63M	-21.67M	-16.21M	39.80M	-4.95M	-92.37M	29.11M	4.11M	-3.83M	-2.31M	-4.62M	7.83M	-14.05M	-7.02M	-1.35M	2.56M	-790.00K	-319.00K	-208.00K
Income Before Tax	345.62M	498.44M	477.39M	113.91M	365.47M	326.43M	323.43M	222.23M	80.20M	177.42M	119.89M	55.90M	77.61M	159.69M	173.16M	26.36M	194.49M	173.97M	158.49M	126.18M	98.91M	74.55M
Income Before Tax Ratio	14.33%	21.48%	23.61%	7.99%	22.90%	23.94%	29.08%	24.22%	10.04%	24.98%	17.63%	8.15%	11.19%	21.65%	23.52%	3.38%	27.25%	29.03%	31.10%	30.02%	28.76%	27.12%
Income Tax Expense	98.81M	63.66M	78.10M	21.64M	57.44M	48.64M	47.84M	-7.38M	8.69M	19.60M	18.69M	19.47M	6.66M	28.61M	26.79M	18.20M	17.22M	32.04M	30.29M	25.65M	18.65M	18.08M
Net Income	246.07M	434.79M	396.08M	91.28M	306.47M	272.77M	272.92M	229.60M	70.68M	157.83M	101.20M	36.44M	70.95M	131.08M	146.37M	8.16M	175.87M	141.73M	127.86M	99.95M	80.30M	55.97M
Net Income Ratio	10.20%	18.73%	19.59%	6.40%	19.20%	20.00%	24.54%	25.02%	8.85%	22.22%	14.88%	5.31%	10.23%	17.77%	19.88%	1.05%	24.64%	23.65%	25.09%	23.78%	23.35%	20.36%
EPS	1.54	2.73	2.49	0.57	1.93	0.17	0.18	0.15	0.05	0.10	0.07	0.02	0.05	0.08	0.09	0.01	0.11	0.09	0.08	0.06	0.05	0.04
EPS Diluted	1.54	2.72	2.48	0.57	1.93	0.17	0.18	0.15	0.04	0.10	0.07	0.02	0.05	0.08	0.09	0.01	0.11	0.09	0.08	0.06	0.05	0.04
Weighted Avg Shares Out	159.40M	159.31M	159.07M	158.83M	158.53M	1.58B	1.55B	1.56B	1.57B	1.56B	1.55B	1.55B	1.56B	1.57B	1.56B	1.56B	1.56B	1.56B	1.56B	1.55B	1.55B	1.55B
Weighted Avg Shares Out (Dil)	159.60M	159.57M	159.59M	159.25M	159.14M	1.59B	1.56B	1.57B	1.58B	1.57B	1.56B	1.55B	1.56B	1.57B	1.56B	1.56B	1.56B	1.56B	1.56B	1.56B	1.55B	1.55B

Straumann: A Swiss Leader Trading At A Favorable Valuation

December 20, 2022seekingalpha.com

Straumann is a Swiss company that is a leader in dental replacement and orthodontic solutions. Straumann's products include dental implants, abutments, clear aligners, biomaterials, and computer-aided design/computer-aided manufacturing equipment. Total stock returns are high, averaging 27% per year over the...

Straumann Holding AG (SAUHF) Q3 2022 Earnings Call Transcript

November 5, 2022seekingalpha.com

Straumann Holding AG (OTCPK:SAUHF) Q3 2022 Results Conference Call November 2, 2022 5:30 AM ET Company Participants Guillaume Daniellot - CEO Peter Hackel - CFO Conference Call Participants Christoph Gretler - Credit Suisse Julien Dormois - BNP Paribas Daniel Jelovcan...

Straumann Holding AG (SAUHF) CEO Guillaume Daniellot on Q2 2022 Results - Earnings Call Transcript

August 16, 2022seekingalpha.com

Straumann Holding AG (OTCPK:SAUHF) Q2 2022 Results Conference Call August 16, 2022 4:30 AM ET Company Participants Guillaume Daniellot - Chief Executive Officer Peter Hackel - Chief Financial Officer Conference Call Participants Patrick Wood - Bank of America Chris Gretler...